Pulling SEC filings + quote and writing the call…

QUANTUM X LABS INC.
Next earnings ≈ Aug 13, 2026 · est. from filing cadence
Going-concern digital-ad shell with collapsing revenue, deepening losses, ~$1M cash and heavy dilution — uninvestable at any price.
Net income -$19.3M · FY2025
It screens cheap (~192% below fair value), but the weak fundamentals are why — more potential value trap than bargain.
Despite the "Quantum X Labs" name, the 10-K reveals a tiny Israel-linked digital-advertising business (Viewbix/Gix Media) whose search platform depends overwhelmingly on a single "Gix Major Customer." The auditor (Deloitte network) issued an explicit going-concern paragraph — substantial doubt about the company's ability to continue operating — and management itself flags that it 'may not be able to generate enough cash flow to meet our debt obligations or fund our other liquidity needs.' That is the dominant fact here, and it overrides any apparent cheapness.
The numbers corroborate the distress. Revenue went from a $96.6M peak in FY2022 to $79.6M (FY2023) to $26.9M (FY2024, -66.2%), with FY2025 revenue not even available in the data. Net income has marched the wrong way every year: +$300K (FY2021) → +$28K (FY2022) → -$7.32M → -$12.1M → -$19.3M (FY2025). Operating cash flow is -$2.77M against just $1.02M of cash, and current assets of $1.65M sit below current liabilities of $4.06M — negative working capital (current ratio ~0.41). Accumulated deficit is -$46.0M, gross margin is effectively zero (0.2%), and net margin is -71.6%. R&D has been gutted to $69K (-91.7%), so a 'prepackaged software' company is no longer meaningfully investing in product.
Is QXL a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $45.2M | $96.6M | $79.6M | $26.9M | — |
| Gross profit | $41.0K | — | — | — | — |
| Operating income | $541K | $2.73M | -$7.47M | -$837K | -$2.18M |
| Net income | $300K | $28.0K | -$7.32M | -$12.1M | -$19.3M |
| Diluted EPS | — | $0.00 | $1.97 | $2.69 | $2.28 |
| Net margin | 0.7% | 0.0% | -9.2% | -44.7% | — |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Item 8.01 other-event disclosure with exhibits; specific impact unspecified
Item 5.02 leadership change: officer/director departure or appointment
Q1-26 results under going-concern doubt; revenue keeps sliding
Q1-26 results under going-concern doubt; revenue keeps sliding
Item 5.03 charter/bylaw amendment plus Reg FD and other-event items
Reg FD (7.01) and other-event press release; no financial detail given
Filed S-3 shelf to register securities for future sale; dilution overhang
FY25 10-K: going-concern doubt, net loss widened to $19.3M, revenue down
Entered material agreement and sold unregistered equity (dilutive financing)
Sources: SEC EDGAR (CIK 0000797542, latest 10-Q filed 2026-05-14) · EODHD · Proprietary analysis · as of 6/30/2026, 12:44:54 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 8:44 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-05-31 | Yoresh Eliyahu Director | Acquired (X) | 88.7K @ $0.00 | $8.87 |
| 2026-05-31 | Baranes Yakov Co-CEO | Acquired (X) | 246K @ $0.00 | $24.64 |
| 2026-03-31 | Weiss Amitay Director | Sell | 30.3K @ $2.00 | $60.6K |
| 2026-03-04 | Yoresh Eliyahu Director | Buy | 179K | |
| 2025-09-03 | Yoresh Eliyahu Director | Buy | 260K @ $1.00 | $260K |
| 2025-09-03 | Yoresh Eliyahu Director | Gift | 100K | |
| 2025-07-11 | Yoresh Eliyahu Director | Buy | 5.14K @ $4.86 | $25.0K |
| 2025-06-17 | Yoresh Eliyahu Director | Gift | 405.00 | |
| 2024-06-18 | Yoresh Eliyahu Director | Buy | 2.52K @ $1.00 | $2.52K |
| 2024-06-18 | Marom Shahar Chief Financial Officer | Buy | 1.26K @ $1.00 | $1.26K |
1195 tracked peers · median